Evaluation of Quality of Care - Shared-Care Programme, HA (QoC SCP)
Diabetes mellitus (DM) and hypertension (HT) are major causes of morbidity and among the top 10 causes of deaths in Hong Kong in 2008 (Department of Health 2009). The Hospital Authority (HA) has initiated service improvement through introducing the shared-care (SC) programme to improve the quality of care (QOC) for DM and HT patients. The evaluation on the QOC is an essential part of the programme in order to inform future policy. The Family Medicine Unit (FMU) of the University of Hong Kong (HKU) has been appointed by the HA to carry out the evaluation of the QOC of the programme.
The Action Learning and Audit Spiral methodologies to measure whether the target standard of care intended by the SC programme is achieved. Each SC participating clinic and private medical practitioner (PMP) will be invited to complete a structured evaluation questionnaire. The data of all patients who have enrolled into the programme will be included in the evaluation on the process and outcomes of care. A hundred and thirty participants will be followed up by telephone to evaluate the effect of the programme in quality of life (QOL), patient enablement, and global rating of change in health condition at baseline and 6 months after enrolment. Data on the process of care will be retrieved from the HA medical records.
Main Outcome Measures: The primary outcomes are the proportion of participants who received the criterion process of care and achieved a HbA1c level <7.5%.
Data Analysis: Descriptive statistics on proportions of clinics or subjects meeting the quality of care criteria will be calculated. The outcomes of SC patients will be compared at 6, 12, 24, 36 and 48 months by paired sample t-test. The outcomes between SC patients and control group will be compared by independent sample t-test or Chi-square test.
Hypothesis: The QOC of the SC programme will be determined. Areas of deficiency and possible areas for quality enhancement will be identified. The results of this study will provide empirical evidence on whether the HA's SC programme can achieve equivalent QOC as the usual HA care for diabetes mellitus (DM) patients. The information will be used to guide service planning and policy decision making.
Visão geral do estudo
Status
Condições
Tipo de estudo
Inscrição (Real)
Contactos e Locais
Locais de estudo
-
-
Hksar
-
Hong Kong, Hksar, Hong Kong
- The University of Hong Kong
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Método de amostragem
População do estudo
Descrição
Inclusion Criteria:
- Patients with diabetes mellitus who have received care at the specialist outpatient clinic (SOPC)for at least 2 years, stratified to be of low risk and have normal renal function as defined by the plasma creatinine level.
Exclusion Criteria:
- Patients will be excluded if they are stratified to be at high cardiovascular risk or are suffering end stage renal failure, on dialysis or after transplantation, or on insulin, or do not give consent to be transferred.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
Coortes e Intervenções
Grupo / Coorte |
|---|
|
DM subjects in Hong Kong
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Prazo |
|---|---|
|
Change of the proportion of clinics that have satisfied each of the structure criteria.
Prazo: December, 2010; December, 2011; December, 2012; December, 2013; December, 2014
|
December, 2010; December, 2011; December, 2012; December, 2013; December, 2014
|
|
Change of the proportion of patients who have received with the SC criterion process of care.
Prazo: June, 2011; December, 2011; December, 2012; December, 2013; December, 2014
|
June, 2011; December, 2011; December, 2012; December, 2013; December, 2014
|
|
Change of the proportion of patients who have achieved a HbA1c <7.5%.
Prazo: June, 2011; December, 2011; December, 2012; December, 2013; December, 2014
|
June, 2011; December, 2011; December, 2012; December, 2013; December, 2014
|
Medidas de resultados secundários
Medida de resultado |
Prazo |
|---|---|
|
Low-density lipoprotein (LDL)
Prazo: Baseline, 6, 12, 24, 36 and 48 months after enrollment.
|
Baseline, 6, 12, 24, 36 and 48 months after enrollment.
|
|
Blood pressure (BP)
Prazo: Baseline, 6, 12, 24, 36 and 48 months after enrollment.
|
Baseline, 6, 12, 24, 36 and 48 months after enrollment.
|
|
Body mass index (BMI)
Prazo: Baseline, 6, 12, 24, 36 and 48 months after enrollment.
|
Baseline, 6, 12, 24, 36 and 48 months after enrollment.
|
|
Cardiovascular complications
Prazo: Baseline, 6, 12, 24, 36 and 48 months after enrollment.
|
Baseline, 6, 12, 24, 36 and 48 months after enrollment.
|
|
Patient reported outcomes (PRO) measured by the change in Short Form-12 version 2 (SF-12v2) scores at 6 months.
Prazo: Baseline and 6 months after the first administration of questionnaire.
|
Baseline and 6 months after the first administration of questionnaire.
|
|
Patient reported outcomes (PRO) measured by the change in the Patient Enablement Instrument (PEI) scores at 6 months.
Prazo: Baseline and 6 months after the first administration of questionnaire.
|
Baseline and 6 months after the first administration of questionnaire.
|
|
Patient reported outcomes (PRO) measured by the change in the Global Rating Scale (GRS) at 6 months.
Prazo: Baseline and 6 months after the first administration of questionnaire.
|
Baseline and 6 months after the first administration of questionnaire.
|
|
Service utilization outcomes measured by General Outpatient Clinics (GOPC) attendance rates at baseline and 12, 24, 36 and 48 months after enrollment.
Prazo: Baseline, 12, 24, 36 and 48 months after enrollment
|
Baseline, 12, 24, 36 and 48 months after enrollment
|
|
Service utilization outcomes measured by specialist outpatient clinic (SOPC) attendance rates at baseline and 12, 24, 36 and 48 months after enrollment.
Prazo: Baseline, 12, 24, 36 and 48 months after enrollment
|
Baseline, 12, 24, 36 and 48 months after enrollment
|
|
Service utilization outcomes measured by accident & emergency (A&E) attendance rates at baseline and 12, 24, 36 and 48 months after enrollment.
Prazo: Baseline, 12, 24, 36 and 48 months after enrollment
|
Baseline, 12, 24, 36 and 48 months after enrollment
|
|
Service utilization outcomes measured by hospital attendance rates at baseline and 12, 24, 36 and 48 months after enrollment.
Prazo: Baseline, 12, 24, 36 and 48 months after enrollment
|
Baseline, 12, 24, 36 and 48 months after enrollment
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- HKCTR-1185
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .